Cambridge researchers are helping to lead the fight back against COVID-19, from the use of genomics to track its spread and mathematic modelling to understand infection rates through to innovative screening programmes to keep its students and staff safe.

Cambridge COVID vaccine in clinical trials

14 December 2021

Safety trials are underway for a vaccine developed by Cambridge researchers that could be used as a booster targeting COVID-19 virus variants and relatives that threaten future coronavirus pandemics.

Read more

Hospital-acquired COVID-19 tends to be picked up from other patients, not from healthcare workers

24 Aug 2021

The majority of patients who contracted COVID-19 while in hospital did so from other patients rather than from healthcare workers, concludes a new...

Read more

Heads reveal how ‘overwhelming’ Government guidance held schools back as COVID hit

05 Aug 2021

Headteachers and school leaders have described how an ‘avalanche’ of confused and shifting Government guidance severely impeded schools during the...

Read more

Lab-grown beating heart cells identify potential drug to prevent COVID-19-related heart damage

05 Aug 2021

Cambridge scientists have grown beating heart cells in the lab and shown how they are vulnerable to SARS-CoV-2 infection. In a study published in...

Read more

Tired looking woman

Biological ‘fingerprints’ of long COVID in blood could lead to diagnostic test, say Cambridge scientists

19 Jul 2021

Markers in our blood – ‘fingerprints’ of infection – could help identify individuals who have been infected by SARS-CoV-2, the coronavirus that...

Read more

Should you ditch your mask once restrictions are lifted? A philosopher’s view

16 Jul 2021

Stephen John, lecturer in Philosophy of Public Health, asks whether catching a bus without a mask on closer to riding a bike or punching a stranger.

Generation COVID: pregnancy, birth and postnatal life in the pandemic

15 Jul 2021

Developmental psychologist Sarah Lloyd-Fox looks at experiences of pregnancy and birth during the pandemic for The Conversation.

Graphical representation of COVID-19 and network analysis

Scientists identify 160 new drugs that could be repurposed against COVID-19

30 Jun 2021

Cambridge scientists have identified 200 approved drugs predicted to work against COVID-19 – of which only 40 are currently being tested in COVID-19...

Read more
Healthcare worker wearing FFP3 mask

Upgrading PPE for staff working on COVID-19 wards cut hospital-acquired infections dramatically

29 Jun 2021

When Addenbrooke’s Hospital in Cambridge upgraded its face masks for staff working on COVID-19 wards to filtering face piece 3 (FFP3) respirators, it...

Read more
Man walking past Stay Alert/Save Lives artwork

Key mutations in Alpha variant enable SARS-CoV-2 to overcome evolutionary weak points

29 Jun 2021

One of the key mutations seen in the ‘Alpha variant’ of SARS-CoV-2 – the deletion of two amino acids, H69/V70 – enables the virus to overcome cracks...

Read more

Scanning electron microscope image of SARS-CoV-2 (orange) emerging from the surface of cells (green) cultured in the lab.

Targeting cellular response to SARS-CoV-2 holds promise as new way to fight infection

17 Jun 2021

A new treatment approach focused on fixing cell damage, rather than fighting the virus directly, is effective against SARS-CoV-2 in lab models. If...

Read more

Tackling COVID-19: Research from Economics to get us back to normal

17 Jun 2021

Dr Flavio Toxvaerd discusses the breadth and importance of the Faculty’s research into the current, and future, pandemics.

The power of touch

17 Jun 2021

As a major Fitzwilliam Museum exhibition explores human touch through 4,000 years of art, Cambridge researchers explain why this sense is so...

Read more